+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
MANKIND

Mankind Pharma Share Price

 
33.32% Gain from 52W Low

 

Mankind Pharma live price: ₹2,546.00. It opened at ₹2,550 vs previous close ₹2,543; intraday high/low: ₹2,557/₹2,532. The 50 & 200 DMA stand at ₹2,427.50/₹2,326.90.

Mankind Pharma Performance

  • Today's Low
  • ₹2,532
  • Today's High
  • ₹2,557
  • 52 Week Low
  • ₹1,910
  • 52 Week High
  • ₹2,695
  • Open Price₹2,550
  • Previous Close₹2,543
  • Volume354,358
  • 50 DMA₹2,427.50
  • 100 DMA₹2,354.40
  • 200 DMA₹2,326.90

Mankind Pharma Chart

Investment Returns

  • Over 1 Month + 6.96%
  • Over 3 Month + 19.96%
  • Over 6 Month + 13.44%
  • Over 1 Year -3.96%

Smart Investing Starts Here Start SIP with Mankind Pharma for Steady Growth!

Invest Now

Mankind Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 55
  • PEG Ratio
  • -14
  • Market Cap Cr
  • 105,149
  • P/B Ratio
  • 6.5
  • Average True Range
  • 64.8
  • EPS
  • 46.3
  • Dividend Yield
  • 0
  • MACD Signal
  • 34.6
  • RSI
  • 59.78
  • MFI
  • 77.01

Latest Stock News Updates

Mankind Pharma Ltd - 543904 - Board Meeting Intimation for Approval Of Financial Results

Mankind Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter ended on June 30, 2026

Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Diversification / Disinvestment

Board of Directors of the Company has approved the divestment of 100 % stake held in Broadway Hospitality Services Private Limited, a wholly owned subsidiary company

Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Acquisition

Board of Directors of the Company in its meeting held today i.e., July 11, 2026 has approved the incorporation of a wholly owned subsidiary in Netherlands

Mankind Pharma Financials

Mankind Pharma Technicals

EMA & SMA

Current Price
₹2,546.00
+ 2.9 (0.11%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹2,498.70
  • 50 Day
  • ₹2,427.50
  • 100 Day
  • ₹2,354.40
  • 200 Day
  • ₹2,326.90

Resistance and Support

2544.9 Pivot Speed
  • R3 2,582.80
  • R2 2,569.80
  • R1 2,557.90
  • S1 2,533.00
  • S2 2,520.00
  • S3 2,508.10

Mankind Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-19 Audited Results
2026-02-03 Quarterly Results
2025-11-06 Quarterly Results
2025-07-31 Quarterly Results & Interim Dividend
2025-05-21 Audited Results
Date Purpose Remarks
2025-08-08 INTERIM Rs.1.00 per share(100%)Interim Dividend
View Mankind Pharma Dividend History Arrow

Mankind Pharma F&O

Mankind Pharma Shareholding Pattern

72.66%
10.36%
10.24%
4.1%
2.63%

About Mankind Pharma

Mankind Pharma is principally engaged in the manufacturing and trading of pharmaceuticals and health care products. Pursuant to scheme of amalgamation, the Company has three manufacturing facilities at Paonta Sahib in the state of Himachal Pradesh, one manufacturing facility in state of Sikkim, two manufacturing facilities in state of Rajasthan, one manufacturing facility in state of Andhra Pradesh, three in-house research and development centres in the state of Haryana and one research and development centre in the state of Maharashtra to carry out research in pharmaceutical products. View More
  • NSE Symbol
  • MANKIND
  • BSE Symbol
  • 543904
  • ISIN
  • INE634S01028

Similar Stocks to Mankind Pharma

Mankind Pharma FAQs

Mankind Pharma share price is ₹2,546 As on 16 July, 2026 | 22:32

The Market Cap of Mankind Pharma is ₹105148.8 Cr As on 16 July, 2026 | 22:32

The P/E ratio of Mankind Pharma is 55 As on 16 July, 2026 | 22:32

The PB ratio of Mankind Pharma is 6.5 As on 16 July, 2026 | 22:32

The 52 week High & Low of Mankind Pharma is ₹2694.9/₹1909.7 respectively As on 16 July, 2026 | 22:32

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23